Arkolith/Insider Trading/QCLS/Form 4

PharmaCyte Biotech, Inc.

10% OwnerQ/C TECHNOLOGIES, INC. (QCLS) · full profile →Form 4 · filed Nov 18, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 14, 2025Buy(P)890K——890K
Sep 4, 2025Buy(P)890K——890K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683168-25-008517) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML